Obesity in people living with type 1 diabetes.

Published on Sep 30, 2021in The Lancet Diabetes & Endocrinology32.069
路 DOI :10.1016/S2213-8587(21)00246-1
Bart Van der Schueren21
Estimated H-index: 21
(Katholieke Universiteit Leuven),
Darcy Ellis (Katholieke Universiteit Leuven)+ 3 AuthorsChantal Mathieu116
Estimated H-index: 116
(Katholieke Universiteit Leuven)
Source
Abstract
Summary null Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. Non-physiological insulin replacement that causes peripheral hyperinsulinaemia, insulin profiles that do not match basal and mealtime insulin needs, defensive snacking to avoid hypoglycaemia, or a combination of these, are believed to affect body composition and drive excessive accumulation of body fat in people with type 1 diabetes. The consequences of overweight or obesity in people with type 1 diabetes are of particular concern, as they increase the risk of both diabetes-related and obesity-related complications, including cardiovascular disease, stroke, and various types of cancer. In this Review, we summarise the current understanding of the aetiology and consequences of excessive bodyweight in people with type 1 diabetes and highlight the need to optimise future prevention and treatment strategies in this population.
馃摉 Papers frequently viewed together
200219.11Diabetes Care
1 Author (Matti Uusitupa)
2015
1 Author (Muili Lawal)
References88
Newest
#1Nagi H. S. Mohammed (ICL: Imperial College London)H-Index: 1
#2Adam Buckley (ICL: Imperial College London)H-Index: 7
Last. Mohamed Suliman (ICL: Imperial College London)H-Index: 7
view all 9 authors...
AIMS Patients with coexisting type 1 diabetes and obesity are increasingly choosing to undergo bariatric surgery for weight management. Effectiveness and safety of bariatric surgery in this group is not established. MATERIALS AND METHODS Retrospective, longitudinal review of clinical data of patients with type 1 diabetes, followed up at our Centre after bariatric surgery was performed elsewhere. RESULTS Sixty-one patients were included, 51% female, 57 (93%) Emirati Arab, 3 (5%) other Arab, 1 (2%...
Source
#1Raquel N. Faradji-Haz谩n (Tec: Monterrey Institute of Technology and Higher Education)H-Index: 1
view all 16 authors...
BACKGROUND Information regarding diagnosis, treatment, and follow-up of patients with type 1 diabetes (PWT1D) in Mexico is limited. We developed an on-line platform Registro Nacional de Pacientes con Diabetes Tipo 1 (RENACED-DT1). OBJECTIVE The objective of the study was to describe the characteristics and healthcare of PWT1D registered in RENACED-DT1. METHODS Analyses of 965 PWT1D from July 2014 to January 2018 in different endocrinology clinics around Mexico. RESULTS Sixty-one percent were fem...
Source
OBJECTIVE Achieving good metabolic control in people with type 1 diabetes (T1D) remains a challenge, despite the evolutions in diabetes technologies over the past decade. Here we investigate the evolution of metabolic control in people with T1D, where care is provided by specialized centres with access to technology, diabetes education and regular follow-up. METHODS Data were cross-sectionally collected between 2010 and 2018 from more than 100 centres in Belgium. The evolutions over time of HbA1...
Source
BACKGROUND The feasibility of measuring 尾-hydroxybutyrate in ISF using a continuous ketone monitoring (CKM) sensor using a single calibration without further adjustments over 14鈥塪ays is described. METHODS A CKM sensor was developed using wired enzyme technology with 尾-hydroxybutyrate dehydrogenase chemistry. In vitro characterization of the sensor was performed in phosphate buffered saline at 37掳C. In vivo performance was evaluated in 12 healthy participants on low carbohydrate diets, who wore 3...
Source
#1Ioannis Avgerinos (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 5
#2Apostolos Manolopoulos (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 4
Last. Eleni Bekiari (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 17
view all 10 authors...
Aim To assess the efficacy and safety of glucose-lowering drugs used as adjunct to insulin therapy in adults with type 1 diabetes. Methods We searched Medline, Embase, and the Cochrane Central Register of Controlled Trials up to January 24, 2020 for randomised controlled trials. Our primary outcome was change in HbA1c . We additionally assessed 8 efficacy and 6 safety secondary endpoints. We performed random-effects frequentist network meta-analysis to estimate mean differences (MDs) and odds ra...
Source
Aims This pooled analysis of the DEPICT-1 and -2 trials aimed to evaluate the efficacy and safety of adjunct dapagliflozin therapy in patients with type 1 diabetes (T1D). Materials and methods DEPICT-1 and -2 were randomized, double-blind, parallel-group, 24-week studies, with 28-week extension periods. Adults with T1D and HbA1c 7.5-10.5% were randomized (1:1:1) to receive dapagliflozin 5, 10 mg or placebo. The short- and long-term efficacy and safety of dapagliflozin were examined in an explora...
Source
#1Saniya Tandon ('KCL': King's College London)H-Index: 1
#2Salma Ayis ('KCL': King's College London)H-Index: 33
Last. Marietta Stadler ('KCL': King's College London)H-Index: 21
view all 5 authors...
Aim To systematically review the effects of pharmacological and lifestyle interventions on body weight as a secondary outcome in people with type 1 diabetes. Methods The Ovid Medline, Embase and Cochrane Library databases were searched for relevant pharmacological (glucagon-like peptide-1 [GLP-1] receptor agonist, sodium-glucose co-transporter-2 [SGLT-2] inhibitor, dipeptidyl peptidase-4 [DPP-4] inhibitor and metformin) and lifestyle intervention studies (diet and exercise) for adults with type ...
Source
#1Vasanti S. Malik (Harvard University)H-Index: 51
#2Walter C. WilletH-Index: 1
Last. Frank B. HuH-Index: 281
view all 3 authors...
In the past decade, the prevalence of obesity and related comorbidities has continued to increase across the globe, prompting many countries to adopt policies to improve diet quality. Here, we discuss key nutrition policies that have been implemented in the past few years and consider future priorities for global obesity prevention.
Source
#1Helena W. RodbardH-Index: 37
#2Andrea Giaccari (UCSC: Catholic University of the Sacred Heart)H-Index: 33
Last. Rita CastroH-Index: 3
view all 8 authors...
AIMS Insulin intensification is associated with weight gain, which may negate the benefits of improved glycemic control in adults with type 1 diabetes (T1D). This post hoc analysis evaluated whether the addition of sotagliflozin to optimised insulin significantly increases the proportion of adults with T1D who achieve HbA1c goals without weight gain. MATERIALS AND METHODS In a patient-level pooled analysis (n聽=聽1575) of data from two phase 3, 52-week clinical trials (inTandem1 and inTandem2), th...
Source
#1Gudrun H枚skuldsdottir (University of Gothenburg)H-Index: 3
#2Jan EkelundH-Index: 3
Last. Bj枚rn Eliasson (University of Gothenburg)H-Index: 66
view all 10 authors...
OBJECTIVE To study the potential long-term benefits and possible complications of bariatric surgery in patients with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS In this register-based nationwide cohort study, we compared individuals with T1D and obesity who underwent Roux-en-Y gastric bypass (RYGB) surgery with patients with T1D and obesity matched for age, sex, BMI, and calendar time that did not undergo surgery. By linking the Swedish National Diabetes Register and Scandinavian Obesity ...
Source
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.